Amălinei Cornelia, Aignătoaei Anda Maria, Balan Raluca Anca, Giuşcă Simona Eliza, Lozneanu Ludmila, Avădănei Elena Roxana, Căruntu Irina Draga
Department of Morphofunctional Sciences I - Histology, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania;
Rom J Morphol Embryol. 2018;59(1):13-22.
Endometrioid endometrial carcinoma has an overall good prognosis. However, variable five-year survival rates (92%-42%) have been reported in FIGO stage I, suggesting the involvement of other factors related to tumor biological behavior. These may be related to the role played by epithelial-mesenchymal transition (EMT) and cancer stem cells in endometrial carcinogenesis. In this context, our review highlights the prognostic significance of several types of myoinvasion in low grade, low stage endometrioid endometrial carcinoma, as a reflection of these molecular changes at the invasive front. According to recently introduced myoinvasive patterns, the diffusely infiltrating and microcystic, elongated, and fragmented (MELF) patterns show loss of hormone receptors, along with EMT and high expression of cancer stem cell markers, being associated with a poor prognosis. Additionally, MELF pattern exhibits a high incidence of lymphovascular invasion and lymph node metastases. Conversely, the broad front pattern has a good prognosis and a low expression of EMT and stem cells markers. Similarly, the adenomyosis (AM)-like and adenoma malignum patterns of invasion are associated to a favorable prognosis, but nevertheless, they raise diagnostic challenges. AM-like pattern must be differentiated from carcinoma invasion of AM foci, while adenoma malignum pattern creates difficulties in appreciating the depth of myoinvasion and requires differential diagnosis with other conditions. Another pattern expecting its validation and prognostic significance value is the nodular fasciitis-like stroma and large cystic growth pattern. In practice, the knowledge of these patterns of myoinvasion may be valuable for the correct assessment of stage, may improve prognosis evaluation and may help identify molecules for future targeted therapies.
子宫内膜样腺癌总体预后良好。然而,据报道,国际妇产科联盟(FIGO)I期患者的五年生存率差异较大(92%-42%),这表明还有其他与肿瘤生物学行为相关的因素。这些因素可能与上皮-间质转化(EMT)和癌症干细胞在子宫内膜癌发生过程中所起的作用有关。在此背景下,我们的综述强调了几种肌层浸润类型在低级别、低分期子宫内膜样腺癌中的预后意义,以此反映侵袭前沿的这些分子变化。根据最近引入的肌层浸润模式,弥漫性浸润以及微囊状、细长和破碎状(MELF)模式显示激素受体缺失,同时伴有EMT和癌症干细胞标志物的高表达,与预后不良相关。此外,MELF模式的淋巴管浸润和淋巴结转移发生率较高。相反,宽前沿模式预后良好,EMT和干细胞标志物表达较低。同样,子宫腺肌病(AM)样和恶性腺瘤样浸润模式与预后良好相关,但它们仍带来诊断挑战。AM样模式必须与癌浸润的AM病灶相鉴别,而恶性腺瘤样模式在判断肌层浸润深度方面存在困难,需要与其他情况进行鉴别诊断。另一种有待验证及其预后意义价值的模式是结节性筋膜炎样间质和大囊状生长模式。在实际应用中,了解这些肌层浸润模式可能有助于正确评估分期、改善预后评估,并有助于识别未来靶向治疗的分子。